Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients
Status:
Recruiting
Trial end date:
2021-09-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate of efficacy and safety of HCP1904-2 and RLD2001-2
alone in patients with essential hypertension inadequately controlled on RLD2001-2
monotherapy.